Latest filing published 07 Dec 2023 for Moderna, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Arpa Garay: trading record in brief
Filings by Arpa Garay span 2 companies, the busiest being Merck & Co., Inc. and Moderna, Inc. In total, 12 filings cover trades dated from 1 May 2022 to 6 December 2023.
No open-market purchase appears, only 3 sales worth €368k. Besides market trades, the filings include 3 share grants and 6 option exercises. So far in 2023, the count stands at no purchases and 3 sales.
On 7 December 2023 came the latest disclosure, an open-market sale for €41k in Moderna, Inc. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Arpa Garay
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,141 sharesCommon StockSEC:0001127602-23-029050:0
- 1,140 sharesCommon StockSEC:0001127602-23-023856:0
- 4,562 sharesCommon StockSEC:0001127602-23-018126:0
- 907 shares@ US$87.1035.1% of flowCommon StockSEC:0001127602-22-013544:0
- 773 shares@ US$87.6530.4% of flowCommon StockSEC:0001127602-22-013210:0
- 866 shares@ US$88.6934.4% of flowCommon StockSEC:0001127602-22-013015:0
6 of 6 declarations
